Bacil Pharma has informed that the Meeting of Board of Directors of the Company will be held on January 30, 2017, to consider and approve the Unaudited Financial Results of the Company for the Quarter and Nine Month ended December 31, 2016. Further, pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in securities of the Company would remain closed for all the employees/Directors/designated persons of the Company from January 21, 2017 to February 01, 2017.
The above information is a part of company’s filings submitted to BSE.
